These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 27877090)
41. Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities. Shimizu M; Yano H; Nagashima S; Murayama N; Zhang J; Cashman JR; Yamazaki H Drug Metab Dispos; 2007 Mar; 35(3):328-30. PubMed ID: 17142560 [TBL] [Abstract][Full Text] [Related]
42. Effects of rapeseed meal on laying hens (Gallus domesticus) in relation to fatty liver-haemorrhagic syndrome and egg taint. Pearson AW; Butler EJ; Curtis RF; Fenwick GR; Hobson-Frohock A; Land DG; Hall SA Res Vet Sci; 1978 Nov; 25(3):307-13. PubMed ID: 749083 [TBL] [Abstract][Full Text] [Related]
43. Novel variants in outer protein surface of flavin-containing monooxygenase 3 found in an Argentinian case with impaired capacity for trimethylamine N-oxygenation. Dionisio L; Shimizu M; Stupniki S; Oyama S; Aztiria E; Alda M; Yamazaki H; Spitzmaul G Drug Metab Pharmacokinet; 2020 Aug; 35(4):383-388. PubMed ID: 32653296 [TBL] [Abstract][Full Text] [Related]
44. [Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-]. Shimizu M Yakugaku Zasshi; 2009 Nov; 129(11):1351-6. PubMed ID: 19881207 [TBL] [Abstract][Full Text] [Related]
46. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis. Liang X; Zhang Z; Lv Y; Tong L; Liu T; Yi H; Zhou X; Yu Z; Tian X; Cui Q; Yang J; Gong P; Zhang L Nutrition; 2020; 79-80():110941. PubMed ID: 32858376 [TBL] [Abstract][Full Text] [Related]
47. Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population. Park CS; Chung WG; Kang JH; Roh HK; Lee KH; Cha YN Pharmacogenetics; 1999 Apr; 9(2):155-64. PubMed ID: 10376762 [TBL] [Abstract][Full Text] [Related]
48. Dietary supplementation of organic selenium could improve performance, antibody response, and yolk oxidative stability in laying hens fed on diets containing oxidized fat. Laika M; Jahanian R Biol Trace Elem Res; 2015 Jun; 165(2):195-205. PubMed ID: 25653003 [TBL] [Abstract][Full Text] [Related]
49. Transcriptome profile of liver at different physiological stages reveals potential mode for lipid metabolism in laying hens. Li H; Wang T; Xu C; Wang D; Ren J; Li Y; Tian Y; Wang Y; Jiao Y; Kang X; Liu X BMC Genomics; 2015 Oct; 16():763. PubMed ID: 26452545 [TBL] [Abstract][Full Text] [Related]
50. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Bennett BJ; de Aguiar Vallim TQ; Wang Z; Shih DM; Meng Y; Gregory J; Allayee H; Lee R; Graham M; Crooke R; Edwards PA; Hazen SL; Lusis AJ Cell Metab; 2013 Jan; 17(1):49-60. PubMed ID: 23312283 [TBL] [Abstract][Full Text] [Related]
51. Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children. Chalmers RA; Bain MD; Michelakakis H; Zschocke J; Iles RA J Inherit Metab Dis; 2006 Feb; 29(1):162-72. PubMed ID: 16601883 [TBL] [Abstract][Full Text] [Related]
53. Hif-1α expression targets the TMA/Fmo3/TMAO axis to participate in gallbladder cholesterol stone formation in individuals living in plateau regions. Luo M; Chen P; Tian Y; Rigzin N; Sonam J; Shang F; Tai C; Li T; Sang H Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167188. PubMed ID: 38657913 [TBL] [Abstract][Full Text] [Related]
54. Trimethylamine N-oxygenation in cynomolgus macaques genotyped for flavin-containing monooxygenase 3 (FMO3). Shimizu M; Uno Y; Utoh M; Yamazaki H Drug Metab Pharmacokinet; 2020 Dec; 35(6):571-573. PubMed ID: 32967780 [TBL] [Abstract][Full Text] [Related]
55. A novel mutation in the flavin-containing monooxygenase 3 gene, FM03, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy. Murphy HC; Dolphin CT; Janmohamed A; Holmes HC; Michelakakis H; Shephard EA; Chalmers RA; Phillips IR; Iles RA Pharmacogenetics; 2000 Jul; 10(5):439-51. PubMed ID: 10898113 [TBL] [Abstract][Full Text] [Related]
56. Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease. Phillips IR; Shephard EA Xenobiotica; 2020 Jan; 50(1):19-33. PubMed ID: 31317802 [TBL] [Abstract][Full Text] [Related]
57. Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population. Shimizu M; Allerston CK; Shephard EA; Yamazaki H; Phillips IR Br J Clin Pharmacol; 2014 May; 77(5):839-51. PubMed ID: 24028545 [TBL] [Abstract][Full Text] [Related]
58. Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine Veeravalli S; Karu K; Scott F; Fennema D; Phillips IR; Shephard EA Drug Metab Dispos; 2018 Jan; 46(1):20-25. PubMed ID: 29070510 [TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles. Cashman JR; Xiong Y; Lin J; Verhagen H; van Poppel G; van Bladeren PJ; Larsen-Su S; Williams DE Biochem Pharmacol; 1999 Sep; 58(6):1047-55. PubMed ID: 10509757 [TBL] [Abstract][Full Text] [Related]
60. Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver. Xu M; Bhatt DK; Yeung CK; Claw KG; Chaudhry AS; Gaedigk A; Pearce RE; Broeckel U; Gaedigk R; Nickerson DA; Schuetz E; Rettie AE; Leeder JS; Thummel KE; Prasad B J Pharmacol Exp Ther; 2017 Nov; 363(2):265-274. PubMed ID: 28819071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]